Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-12-20Clinical Trial Update: Can Quercetin Increase Claudin-4 and Improve Esophageal Barrier Function in GERD? [Phase 1]
A Phase 1 trial evaluated whether quercetin can increase claudin-4 and improve esophageal barrier function in Gastroesophageal Reflux Diseas…
-
CLINICAL_TRIALS trial_result · 2016-12-19Clinical Trial Update: Can E-cadherin Found in Tissue/Blood be Valuable in Identifying & Monitoring Patients With Post-proton Pump Inhibitor (PPI)-Responsive Heartburn [Phase 1]
A Phase 1 clinical trial investigated whether E-cadherin levels in tissue or blood could help identify and monitor patients with heartburn a…
-
CLINICAL_TRIALS research · 2016-12-07Clinical Trial Update: Effect of Proton Pump Inhibitor and Mosapride on Acid Pocket in Gastroesophageal Reflux Disease [NA]
This clinical trial update examines the effect of a proton pump inhibitor and mosapride on the acid pocket in gastroesophageal reflux diseas…
-
FDA approval · 2016-12-06FDA Approved: OMEPRAZOLE SODIUM BICARBONATE — Original Application (Cipla USA Inc.)
FDA approves Cipla USA Inc.'s original application for Omeprazole Sodium Bicarbonate (generic). This is a generic omeprazole-sodium bicarbon…
-
FDA approval · 2016-12-01FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
The FDA approved a supplemental application for Good Neighbor Pharmacy Omeprazole (omeprazole) from AmerisourceBergen, updating labeling and…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA withdrawal · 2016-11-15EMA Withdrawn: Pantecta Control (pantoprazole) — Takeda GmbH
EMA confirms withdrawal of Pantecta Control (pantoprazole) from the market by Takeda GmbH, related to gastroesophageal reflux treatment.
-
CLINICAL_TRIALS research · 2016-11-15Clinical Trial Update: GERD and Anti-Reflux Therapy Between Able-bodied and SCI Individuals [Phase 1]
Phase 1 clinical trial investigating anti-reflux therapy for gastroesophageal reflux disease in able-bodied versus spinal cord injury indivi…
-
CLINICAL_TRIALS trial_result · 2016-11-08Clinical Trial Update: The Efficacy of Lansoprazole and Domperidone Combination on Intragastric and Intraesophageal Acidity [Phase 4]
A Phase 4 trial assesses the efficacy of combining lansoprazole with domperidone to reduce intragastric and intraesophageal acidity in patie…
-
FDA approval · 2016-11-07FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Original Application (Aurohealth LLC)
FDA approved a new original application for the combination product omeprazole and sodium bicarbonate (Aurohealth LLC) intended for gastroes…
-
FDA approval · 2016-10-24FDA Approved: PRILOSEC — Supplemental Application (Covis Pharma US, Inc)
FDA approved a supplemental application for Prilosec (omeprazole magnesium) submitted by Covis Pharma US, Inc.
-
FDA approval · 2016-10-24FDA Approved: ACIPHEX — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for ACIPHEX (rabeprazole sodium) submitted by Waylis Therapeutics LLC.
-
FDA approval · 2016-10-24FDA Approved: ESOMEPRAZOLE STRONTIUM — Supplemental Application (R2 Pharma, LLC)
The FDA approved a supplemental application to authorize the marketing of esomeprazole strontium, a salt form of esomeprazole, for use in th…
-
FDA approval · 2016-10-24FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for the combination product omeprazole and sodium bicarbonate from Oceanside Pharmaceuticals.
-
CLINICAL_TRIALS research · 2016-10-19Clinical Trial Update: Symptom Assessment for Patients With Gastro-esophageal Reflux Disease Receiving Helicobacter Pylori Eradication [Phase 4]
Phase 4 clinical trial update examining symptom assessment in patients with gastroesophageal reflux disease undergoing Helicobacter pylori e…
-
CLINICAL_TRIALS research · 2016-10-18Clinical Trial Update: STRETTA ,Radio Frequency Ablation (RFA) v/s Sham Therapy for the Treatment of Refractory GERD [Phase 3]
Phase 3 clinical trial update evaluating the STRETTA radiofrequency ablation procedure versus sham therapy for refractory gastroesophageal r…
-
FDA approval · 2016-10-14FDA Approved: LANSOPRAZOLE — Original Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA Inc.'s generic lansoprazole under an original ANDA.
-
FDA approval · 2016-10-12FDA Approved: PRILOSEC OTC — Supplemental Application (The Procter & Gamble Manufacturing Company)
FDA approved a supplemental application for Prilosec OTC (omeprazole magnesium) from The Procter & Gamble Manufacturing Company. The approva…
-
CLINICAL_TRIALS trial_result · 2016-10-12Clinical Trial Update: Self-Propelled Percutaneous Endoscopic GastroJejunostomy (PEG-J) [Phase 2]
Phase 2 trial update on a self-propelled percutaneous endoscopic gastrojejunostomy (PEG-J) procedure for gastroesophageal reflux disease; th…
-
CLINICAL_TRIALS trial_result · 2016-10-04Clinical Trial Update: Efficacy and Saafety of Omez Iin Patients With H.Pylori Associated Diseases [Phase 4]
Phase 4 trial evaluating the efficacy and safety of Omez (omeprazole) in patients with gastroesophageal reflux disease, including those with…
-
CLINICAL_TRIALS trial_result · 2016-09-14Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Controlled Release Arbaclofen Placarbil (XP19986) in Patients With Gastroesophageal Reflux Disease [Phase 2]
This update reports the completion of a Phase 2 study evaluating the efficacy and safety of controlled-release arbaclofen placarbil (XP19986…
-
CLINICAL_TRIALS research · 2016-09-08Clinical Trial Update: Factors Influencing the Human Gut Microbiome Profile in Multi-ethnic Groups of the Singapore Community (FAMES) [NA]
Completed clinical trial studying factors influencing the human gut microbiome profile in multi-ethnic groups in Singapore with gastroesopha…
-
CLINICAL_TRIALS trial_result · 2016-09-05Clinical Trial Update: Relationship of Obesity With GERD Among Nigerians
A completed clinical trial from Obafemi Awolowo University Teaching Hospital examining the relationship between obesity and gastroesophageal…
-
FDA approval · 2016-08-10FDA Approved: ESOMEPRAZOLE SODIUM — Original Application (Eugia US LLC)
FDA approved Eugia US LLC's original application for esomeprazole sodium, a generic proton pump inhibitor, confirming a generic version of t…
-
CLINICAL_TRIALS trial_result · 2016-08-09Clinical Trial Update: Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients [Phase 3]
A Phase 3 clinical trial evaluating ilaprazole for gastroesophageal reflux disease in Chinese patients has completed. The snippet does not i…
-
CLINICAL_TRIALS trial_result · 2016-08-05Clinical Trial Update: Elucidation of Acid-Induced Pulmonary Inflammation [Phase 2, Phase 3]
A Phase 2/3 clinical trial investigating acid-induced pulmonary inflammation related to gastroesophageal reflux disease and asthma was termi…